Variant report
Variant | rs12630564 |
---|---|
Chromosome Location | chr3:160170243-160170244 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:34)
- CpG islands (count:122)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:34 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr3:160170070-160170253 | HUVEC | blood vessel: | n/a | n/a |
2 | POLR2A | chr3:160170169-160170273 | A549 | lung: | n/a | n/a |
3 | ELF1 | chr3:160170069-160170324 | K562 | blood: | n/a | chr3:160170228-160170241 chr3:160170178-160170187 |
4 | MYC | chr3:160170113-160170306 | MCF-7 | breast: | n/a | n/a |
5 | HEY1 | chr3:160170121-160170367 | K562 | blood: | n/a | n/a |
6 | POLR2A | chr3:160170167-160170421 | GM12878 | blood: | n/a | n/a |
7 | POLR2A | chr3:160170033-160170267 | A549 | lung: | n/a | n/a |
8 | POLR2A | chr3:160169983-160170265 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | USF1 | chr3:160170178-160170371 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | POLR2A | chr3:160170136-160170303 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | ELF1 | chr3:160170048-160170358 | K562 | blood: | n/a | chr3:160170228-160170241 chr3:160170178-160170187 |
12 | POLR2A | chr3:160170071-160170262 | MCF-7 | breast: | n/a | n/a |
13 | POLR2A | chr3:160169978-160170262 | Hela-S3 | cervix: | n/a | n/a |
14 | POLR2A | chr3:160170165-160170249 | HepG2 | liver: | n/a | n/a |
15 | POLR2A | chr3:160169996-160170659 | K562 | blood: | n/a | n/a |
16 | HEY1 | chr3:160170101-160170304 | HepG2 | liver: | n/a | n/a |
17 | MYC | chr3:160170133-160170259 | MCF-7 | breast: | n/a | n/a |
18 | POLR2A | chr3:160170152-160170325 | A549 | lung: | n/a | n/a |
19 | POLR2A | chr3:160170148-160170382 | A549 | lung: | n/a | n/a |
20 | POLR2A | chr3:160170075-160170260 | GM12878 | blood: | n/a | n/a |
21 | MYC | chr3:160170169-160170254 | HUVEC | blood vessel: | n/a | n/a |
22 | POLR2A | chr3:160170145-160170327 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | CTCF | chr3:160170209-160170245 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr3:160169970-160170389 | MCF-7 | breast: | n/a | n/a |
25 | POLR2A | chr3:160169973-160170263 | ProgFib | skin: | n/a | n/a |
26 | MYC | chr3:160170191-160170247 | MCF-7 | breast: | n/a | n/a |
27 | MAX | chr3:160170100-160170344 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | POLR2A | chr3:160170148-160170331 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr3:160170148-160170341 | Hela-S3 | cervix: | n/a | n/a |
30 | POLR2A | chr3:160170167-160170303 | A549 | lung: | n/a | n/a |
31 | POLR2A | chr3:160170051-160170584 | MCF-7 | breast: | n/a | n/a |
32 | POLR2A | chr3:160170034-160170268 | HepG2 | liver: | n/a | n/a |
33 | POLR2A | chr3:160169980-160170265 | Gliobla | brain: | n/a | n/a |
34 | POLR2A | chr3:160170095-160170323 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:160170225-160170275 | HCM | heart: | n/a |
2 | chr3:160170242-160170292 | MCF10A-Er-Src | breast: | n/a |
3 | chr3:160170242-160170292 | GM19239 | blood: | n/a |
4 | chr3:160170225-160170275 | ProgFib | skin: | n/a |
5 | chr3:160170242-160170292 | HUVEC | blood vessel: | n/a |
6 | chr3:160170242-160170292 | GM12878 | blood: | n/a |
7 | chr3:160170242-160170292 | K562 | blood: | n/a |
8 | chr3:160170225-160170275 | AG04449 | skin: | fetal |
9 | chr3:160170225-160170275 | Caco-2 | colon: | n/a |
10 | chr3:160170225-160170275 | MCF-7 | breast: | n/a |
11 | chr3:160170225-160170275 | AG10803 | skin: | n/a |
12 | chr3:160170242-160170292 | ECC-1 | luminal epithelium: | n/a |
13 | chr3:160170242-160170292 | Jurkat | blood: | n/a |
14 | chr3:160170242-160170292 | AG10803 | skin: | n/a |
15 | chr3:160170242-160170292 | AG09319 | gingival: | n/a |
16 | chr3:160170242-160170292 | NH-A | brain: | n/a |
17 | chr3:160170225-160170275 | HRPEpiC | eye: | n/a |
18 | chr3:160170242-160170292 | BJ | skin: | n/a |
19 | chr3:160170242-160170292 | NB4 | blood: | n/a |
20 | chr3:160170242-160170292 | HMEC | breast: | n/a |
21 | chr3:160170225-160170275 | GM12892 | blood: | n/a |
22 | chr3:160170242-160170292 | PrEC | prostate: | n/a |
23 | chr3:160170225-160170275 | HEK293 | kidney: | embryo |
24 | chr3:160170225-160170275 | A549 | lung: | n/a |
25 | chr3:160170242-160170292 | PFSK-1 | brain: | n/a |
26 | chr3:160170225-160170275 | SK-N-SH | brain: | n/a |
27 | chr3:160170225-160170275 | LNCaP | prostate: | n/a |
28 | chr3:160170225-160170275 | K562 | blood: | n/a |
29 | chr3:160170242-160170292 | GM06990 | blood: | n/a |
30 | chr3:160170225-160170275 | Hepatocyte | liver: | n/a |
31 | chr3:160170225-160170275 | NT2-D1 | testis: | n/a |
32 | chr3:160170225-160170275 | PFSK-1 | brain: | n/a |
33 | chr3:160170242-160170292 | HPAEpiC | pulmonary alveolar: | n/a |
34 | chr3:160170242-160170292 | SKMC | muscle: | n/a |
35 | chr3:160170242-160170292 | BE2_C | brain: | n/a |
36 | chr3:160170242-160170292 | MCF-7 | breast: | n/a |
37 | chr3:160170242-160170292 | NHBE | bronchial: | n/a |
38 | chr3:160170225-160170275 | U87 | brain: | n/a |
39 | chr3:160170225-160170275 | AG09319 | gingival: | n/a |
40 | chr3:160170242-160170292 | PANC-1 | pancreas: | n/a |
41 | chr3:160170225-160170275 | RPTEC | kidney: | n/a |
42 | chr3:160170242-160170292 | HRE | kidney: | n/a |
43 | chr3:160170242-160170292 | HEEpiC | esophagus: | n/a |
44 | chr3:160170242-160170292 | AG09309 | skin: | n/a |
45 | chr3:160170242-160170292 | U87 | brain: | n/a |
46 | chr3:160170242-160170292 | GM12892 | blood: | n/a |
47 | chr3:160170242-160170292 | AG04449 | skin: | fetal |
48 | chr3:160170225-160170275 | GM06990 | blood: | n/a |
49 | chr3:160170225-160170275 | HCT-116 | colon: | n/a |
50 | chr3:160170242-160170292 | AoSMC | blood vessel: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:160164471..160170330-chr3:160281681..160284179,8 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000244009 | TF binding region |
ENSG00000248710 | TF binding region |
TRIM59 | TF binding region |
ENSG00000244009 | CpG island |
ENSG00000248710 | CpG island |
TRIM59 | CpG island |
ENSG00000229320 | Chromatin interaction |
ENSG00000186432 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10923 | 0.97[AFR][1000 genomes];0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10936201 | 0.90[AFR][1000 genomes];0.88[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs10936203 | 0.83[AFR][1000 genomes];0.95[AMR][1000 genomes];0.89[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs11708118 | 0.88[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs11709232 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11709336 | 0.84[AFR][1000 genomes];0.83[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs11716413 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs11719750 | 0.95[AMR][1000 genomes];0.98[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs11720689 | 0.85[AFR][1000 genomes];0.85[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs11721112 | 0.80[AMR][1000 genomes];0.81[EUR][1000 genomes] |
rs12152435 | 0.80[AFR][1000 genomes];0.92[AMR][1000 genomes];0.88[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12630770 | 0.87[AFR][1000 genomes];0.88[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs12630956 | 0.94[AMR][1000 genomes];0.90[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12638633 | 0.80[AFR][1000 genomes];0.95[AMR][1000 genomes];0.88[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12639488 | 0.89[AMR][1000 genomes];0.88[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs16831207 | 0.81[AFR][1000 genomes];0.88[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs17236494 | 0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17826137 | 0.83[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs17826173 | 0.90[AFR][1000 genomes];0.88[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs17826257 | 0.89[AMR][1000 genomes];0.88[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs1873076 | 0.87[AFR][1000 genomes];0.88[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs1920663 | 0.80[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs2095529 | 0.87[AFR][1000 genomes];0.85[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs2099496 | 0.98[AFR][1000 genomes];0.94[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs2275151 | 0.83[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs3773369 | 0.92[AFR][1000 genomes];0.94[AMR][1000 genomes];0.96[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs4679886 | 0.97[AFR][1000 genomes];0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4679892 | 0.89[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs4680581 | 0.90[AFR][1000 genomes];0.88[AMR][1000 genomes];0.95[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs4680586 | 0.97[AMR][1000 genomes];0.98[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs56952700 | 0.97[AFR][1000 genomes];0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs60395700 | 0.87[AFR][1000 genomes];0.88[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs6441311 | 0.84[AFR][1000 genomes];0.85[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs73875254 | 0.81[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs73875259 | 0.88[AFR][1000 genomes];0.88[AMR][1000 genomes];0.96[EUR][1000 genomes] |
rs73875285 | 0.82[AFR][1000 genomes];0.95[AMR][1000 genomes];0.89[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs73875290 | 0.80[AFR][1000 genomes];0.95[AMR][1000 genomes];0.88[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs7644186 | 0.80[AMR][1000 genomes];0.81[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv532666 | chr3:159777847-160703202 | Enhancers Weak transcription ZNF genes & repeats Strong transcription Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 271 gene(s) | inside rSNPs | diseases |
2 | nsv1000453 | chr3:159853305-160366357 | Active TSS Flanking Active TSS Enhancers Weak transcription Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 259 gene(s) | inside rSNPs | diseases |
3 | nsv536779 | chr3:159853305-160366357 | Strong transcription Enhancers Transcr. at gene 5' and 3' Weak transcription Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 259 gene(s) | inside rSNPs | diseases |
4 | esv1800136 | chr3:159950498-160278160 | Enhancers Weak transcription Active TSS Strong transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 213 gene(s) | inside rSNPs | diseases |
5 | esv1801767 | chr3:159950498-160279411 | Strong transcription Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 213 gene(s) | inside rSNPs | diseases |
6 | nsv1008519 | chr3:160038710-160292589 | Flanking Active TSS Weak transcription Strong transcription ZNF genes & repeats Enhancers Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 255 gene(s) | inside rSNPs | diseases |
7 | esv1801686 | chr3:160089896-160248363 | Strong transcription Weak transcription Flanking Active TSS Enhancers Genic enhancers Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 211 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:160168400-160172600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
2 | chr3:160168400-160172600 | Weak transcription | Brain Substantia Nigra | brain |
3 | chr3:160168400-160172800 | Weak transcription | Brain Anterior Caudate | brain |
4 | chr3:160169800-160171000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr3:160170200-160170400 | Enhancers | Lung | lung |
6 | chr3:160170200-160171400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr3:160170200-160175600 | Weak transcription | K562 | blood |